Pro Nephro AKI (NGAL) is now FDA-Cleared     READ MORE

Mouse monoclonal antibody

Anti-Complement component C9 (human)

CAT NO: ABS 004-22 | Application: ELISA, WB, IHC, IF


Cat. No.

ABS 004-22

Specificity

ABS 004-22 is specific for complement factor C9.

Immunogen

Complement factor C9

Host

Mouse

Positive Species Reactivity

Human

Negative Species Reactivity

Not determined

Isotype

IgG1/k

Gene ID

735

Clone Number

22

Epitope Specificity

Not determined

Unit Size

400 µL: Cat. No. ABS 004-22-04 1 mL: Cat. No. ABS 004-22-1 1 mg/mL +/- 15%. See Certificate of Analysis for details.

Purification

Protein-A/G purified, from culture supernatant

Form

Liquid

Solvent

0.01 M phosphate buffer, pH 7.4, containing 0.5 M NaCl and 15 mM sodium azide

Conjugation

Unconjugated BSA free

Storage

4-8ºC without exposure to light. No precautions necessary during handling.

Target

Complement factor C9 is a 71kDa single-chain ellipsoid a-globular molecule of 558 amino acids including a leader sequence of 20 amino acids. C9 bind the C5b8 complex on membranes and has an unique property in forming tubular structures containing between 12 and 18 monomers, closely resembling the membrane attack complex (MAC). The primary site of synthesis is hepatocytes, secondary sites are monocytes, fibroblasts and glial cells. The normal level of C9 in plasma is 60 µg/mL, and the level is up regulated from hepatocytes by IFN-g.